In searching for new therapies, pharmaceutical research teams worldwide are conducting experiments daily and generating knowledge. Thanks to this constantly expanding pool of scientific data, we are starting projects with access to more information than ever before. Data is good. The right data is better. But finding the right data is no easy task. Inaccessible…
How biologists of the future could displace some data scientists in drug development
A decade ago, data scientist seemed like the sexiest job of the 21st century, to paraphrase an influential Harvard Business Review article. In the pharmaceutical industry, data science certainly continues to have tremendous potential, but in years to come, data-savvy biologists could have as least as much of an impact on drug development as data scientists,…
An intelligent approach to data cleaning
The collection of good quality data from clinical trials is essential to data analysis to produce robust results that meet the precise requirements for regulatory need. Data from clinical trials are increasingly complex, related to involved protocols, the geography of trial sites, increasing data streams and technological advances. Therefore, studies must be set up to…
3 ways to reduce implicit bias in predictive analytics for better health equity
The COVID-19 pandemic has brought into sharp focus the racioethnic and socioeconomic disparities inherent in the U.S. healthcare system. These disparities take the form of increased adverse health outcomes and reduced quality of life for affected groups. For example, a study of cities that reported COVID-19 deaths by race and ethnicity found that 34% of…
Why cyberattacks targeting pharma are ramping up
Cyberattacks targeting the pharma industry have ramped up during the pandemic, and insider threats and nation-state attacks are also on the rise. Meanwhile, the average cost of a pharma breach in 2021 is $5.04 million, according to the IBM-sponsored Ponemon Institute’s Cost of a Data Breach Report. For context, an average data breach incurs damages of $4.24…
Q&A: Keys to unlock data science potential for drug discovery
For all of its promise in healthcare and elsewhere, deploying artificial intelligence is frequently a challenging endeavor. “Close collaboration between data science teams, other project team members and stakeholders is essential,” said Jennifer Bradford, director of data science at Phastar, the London-headquartered contract research organization. While input from computational, statistical or medical experts could be…